311 related articles for article (PubMed ID: 15023465)
1. Oral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats.
Krauland AH; Guggi D; Bernkop-Schnürch A
J Control Release; 2004 Mar; 95(3):547-55. PubMed ID: 15023465
[TBL] [Abstract][Full Text] [Related]
2. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system.
Hombach J; Hoyer H; Bernkop-Schnürch A
Eur J Pharm Sci; 2008 Jan; 33(1):1-8. PubMed ID: 17980561
[TBL] [Abstract][Full Text] [Related]
3. Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
Krauland AH; Guggi D; Bernkop-Schnürch A
Int J Pharm; 2006 Jan; 307(2):270-7. PubMed ID: 16300914
[TBL] [Abstract][Full Text] [Related]
4. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
Palmberger TF; Hombach J; Bernkop-Schnürch A
Int J Pharm; 2008 Feb; 348(1-2):54-60. PubMed ID: 17716840
[TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix.
Guggi D; Kast CE; Bernkop-Schnürch A
Pharm Res; 2003 Dec; 20(12):1989-94. PubMed ID: 14725364
[TBL] [Abstract][Full Text] [Related]
6. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system.
Bernkop-Schnürch A; Guggi D; Pinter Y
J Control Release; 2004 Jan; 94(1):177-86. PubMed ID: 14684281
[TBL] [Abstract][Full Text] [Related]
7. Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation.
Roldo M; Hornof M; Caliceti P; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2004 Jan; 57(1):115-21. PubMed ID: 14729087
[TBL] [Abstract][Full Text] [Related]
8. The use of thiolated polymers as carrier matrix in oral peptide delivery--proof of concept.
Bernkop-Schnürch A; Pinter Y; Guggi D; Kahlbacher H; Schöffmann G; Schuh M; Schmerold I; Del Curto MD; D'Antonio M; Esposito P; Huck C
J Control Release; 2005 Aug; 106(1-2):26-33. PubMed ID: 15939501
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro evaluation of a novel thiolated chitosan.
Kafedjiiski K; Krauland AH; Hoffer MH; Bernkop-Schnürch A
Biomaterials; 2005 Mar; 26(7):819-26. PubMed ID: 15350788
[TBL] [Abstract][Full Text] [Related]
10. Development and in vitro evaluation of a drug delivery system based on chitosan-EDTA BBI conjugate.
Bernkop-Schnürch A; Krauland A; Valenta C
J Drug Target; 1998; 6(3):207-14. PubMed ID: 9888307
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive in vitro and in vivo evaluation of thiolated matrix tablets as a gastroretentive delivery system.
Senyigit ZA; Vetter A; Guneri T; Bernkop-Schnürch A
Drug Deliv; 2011 Aug; 18(6):405-14. PubMed ID: 21463156
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan.
Föger F; Schmitz T; Bernkop-Schnürch A
Biomaterials; 2006 Aug; 27(23):4250-5. PubMed ID: 16618504
[TBL] [Abstract][Full Text] [Related]
13. Improved synthesis and in vitro characterization of chitosan-thioethylamidine conjugate.
Kafedjiiski K; Hoffer M; Werle M; Bernkop-Schnürch A
Biomaterials; 2006 Jan; 27(1):127-35. PubMed ID: 16045983
[TBL] [Abstract][Full Text] [Related]
14. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A
Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of cytotoxicity of a glucosamine-TBA conjugate and a chitosan-TBA conjugate.
Guggi D; Langoth N; Hoffer MH; Wirth M; Bernkop-Schnürch A
Int J Pharm; 2004 Jul; 278(2):353-60. PubMed ID: 15196640
[TBL] [Abstract][Full Text] [Related]
16. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
[TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation of a nasal insulin delivery system based on thiolated chitosan.
Krauland AH; Leitner VM; Grabovac V; Bernkop-Schnürch A
J Pharm Sci; 2006 Nov; 95(11):2463-72. PubMed ID: 16886206
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro evaluation of thiolated hyaluronic acid for mucoadhesive drug delivery.
Kafedjiiski K; Jetti RK; Föger F; Hoyer H; Werle M; Hoffer M; Bernkop-Schnürch A
Int J Pharm; 2007 Oct; 343(1-2):48-58. PubMed ID: 17544606
[TBL] [Abstract][Full Text] [Related]
19. In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein.
Föger F; Hoyer H; Kafedjiiski K; Thaurer M; Bernkop-Schnürch A
Biomaterials; 2006 Dec; 27(34):5855-60. PubMed ID: 16919723
[TBL] [Abstract][Full Text] [Related]
20. Thiolated polymers--thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates.
Bernkop-Schnürch A; Hornof M; Zoidl T
Int J Pharm; 2003 Jul; 260(2):229-37. PubMed ID: 12842342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
